Quantitative reverse transcription assays (qRT-PCR) estimate the FMR1 expression levels to evaluate the full clinical spectrum and resolve the dilemma of overlapped clinical features of PM carriers that could be common with FM cases as ADHD, ASD, depression, and anxiety. Here, FMR1 is linked to depressive symptom measurement.